# Contact Peptide Friend — Editorial Desk

> Reach the Peptide Friend editorial desk regarding citations, corrections, or research-related correspondence about our Cognitive & Nootropic peptide digest.

Correspondence on citations, corrections, and research-related inquiries — the things a reference desk most wants to hear about.

## Editorial correspondence

Peptide Friend welcomes correspondence on the research record: a citation we have quoted inaccurately, a regulatory status that has changed, or a peer-reviewed study about Semax, Selank, or DSIP that should be added to the [references page](/references). Corrections that improve the accuracy of the digest are the most useful messages we receive, and they are read carefully.

The most actionable notes specify three things: the page they refer to, the exact passage in question, and the supporting citation — a DOI or PubMed ID wherever possible. That allows us to verify a proposed change against the source without ambiguity.

**Editorial mailbox:** editors@peptidefriend.com

## What this desk cannot do

So that no message goes unanswered for the wrong reason, a few things fall outside what this site can address. Peptide Friend is a literature digest, not a clinic or a vendor, so we cannot:

- Advise on, recommend, or comment on human use of any compound discussed here.
- Suggest a dose, schedule, or route of administration for any individual.
- Diagnose a condition or assess whether a research finding applies to a particular person's situation.
- Sell, source, recommend, or help locate any compound from any supplier.
- Answer requests from athletes subject to anti-doping rules about using these compounds, given the regulatory uncertainties around non-approved substances.

Readers seeking guidance on anxiety, cognitive impairment, or sleep disorders should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed and may be delayed; the mailbox is monitored intermittently.

---

A skeptic's reading desk: peer-reviewed citations on neuroactive peptides, no doses, no diagnoses, and nothing for sale.